U.S. stock-index futures fell as investors assessed gains after the Nasdaq 100 Index hit a 15-year high and the Standard & Poor’s Index recovered the ground lost in the August selloff.
King Digital Entertainment Plc jumped 14 percent early in New York after the maker of the Candy Crush game agreed to a $5.9 billion takeover from Activision Blizzard Inc. Fitbit Inc. lost 7 percent after announcing plans to sell additional shares. American International Group Inc. slid 3 percent after reporting a third-quarter loss and lower-than-expected operating income. Avis Budget Group Inc. tumbled 9.7 percent in Europe after trimming its annual profit outlook. Allstate Corp. added 1.3 percent after the insurer posted higher-than-estimated quarterly operating income.
S&P 500 Index E-mini contracts expiring in December fell 0.3 percent to 2,089.25 at 7:28 a.m. in New York. Futures on the Nasdaq 100 Index dropped 0.3 percent, while Dow Jones Industrial Average contracts slid 42 points, or 0.2 percent, to 17,693.
“Normally after a big day futures are flat to slightly down as investors pause,” said Nick Ford, a fund manager who helps manage the equivalent of $3.7 billion at Miton Group in London. “Investors are sticking to safety at this point in case things take a turn for the worse on the economic front. The next few weeks of economic data are going to be very important in terms of working out what goes on from here.”
The Nasdaq 100 Index yesterday became the first major U.S. stocks index to retake a multiyear high established earlier in 2015. The S&P 500 rose to its highest level since Aug. 10 — the day before China’s surprise devaluation of its currency sparked turmoil on global financial markets.
King Digital Entertainment PLC (NYSE:KING) stock on Tuesday’s pre market session gained 15.32% at price of $17.92. Over the last one month and the previous three months, King Digital Entertainment PLC’s shares have rose 12.28% and ticked down -1.15%, respectively. Additionally, the stock has surged 7.58% since the beginning of 2015. The company’s shares are trading above their 50-day and 200-day moving averages by 11.21% and 5.78%, respectively. King Digital Entertainment PLC’s stock has a Relative Strength Index (RSI) of 69.99. King Digital Entertainment PLC (NYSE:KING) proclaimed the signing of a definitive agreement under which ABS Partners C.V. (“ABS Partners”), a wholly owned subsidiary of Activision Blizzard, will acquire all of the outstanding shares of King for $18.00 in cash per share, for a total equity value of $5.9 billion (the “Acquisition”). The $18.00 per share purchase price implies a 20% premium over King’s 30 October 2015 closing price, a 26% premium over King’s 30 October 2015 enterprise value (which excludes net cash), a 23% premium over King’s one month volume weighted average price per share and a 27% premium over King’s three month volume weighted average price per share.
On Tuesday’s pre market session, shares in NeoPhotonics Corp (NYSE:NPTN) rose 6.89% at the price of $9.00. NeoPhotonics Corp’s shares have surged 24.48% in the last one month, -1.97% in the previous three months and +149.70% on YTD basis. The company is trading 17.46% up its 50-day moving average and 25.16% above its 200-day moving average. Moreover, shares of NeoPhotonics Corp have an RSI of 63.38. NeoPhotonics Corp (NYSE:NPTN) a foremost designer and manufacturer of advanced hybrid photonic integrated optoelectronic modules and subsystems for bandwidth-intensive, high-speed communications networks, recently announced financial results for its third quarter ended September 30, 2015. Revenue was $83.6 million, up $2.0 million, or 2.4%, from the third quarter of 2014, and down $1.8 million, or 2.1%, from the prior quarter, Gross margin was 28.4%, up from 24.6% in the third quarter of 2014, and down from 30.6% in the prior quarter.
Cellectis SA (ADR) (NASDAQ:CLLS) stocks surged 6.89% in today’s pre market session with the price of $33.50. Over the last one month and over the past three months, Cellectis SA’s shares have gained 15.60% and -9.89%, respectively. Furthermore, the stock has plummeted -20.25% since the start of this year. The company’s shares are trading 7.70% above their 50-day moving average. Additionally, Cellectis SA has an RSI of 66.96 and ATR of 1.71. Cellectis SA (ADR) (NASDAQ:CLLS) publicized that a series of three production runs of UCART19, its lead TALEN® gene edited product candidate, was performed, confirming the implementation of Cellectis’ manufacturing process in GMP conditions. The manufacturing process for Cellectis’ allogeneic CAR T-cell product line, Universal CARTs or UCARTs, yields frozen, off-the-shelf, allogeneic, engineered CAR T-cells. UCARTs are meant to be readily available CAR T-cells for a large patient population. The TALEN®-based gene editing (knock-out of the TCR-alpha and CD52 genes) is designed to suppress T-cell alloreactivity and confer resistance to alemtuzumab to the T-cells.